Aquestive Therapeutics, Inc. (AQST)
3.955
+0.12
(+3.26%)
USD |
NASDAQ |
Feb 19, 16:00
3.95
0.00 (0.00%)
After-Hours: 20:00
Aquestive Therapeutics Profit Margin (Quarterly) : -120.6% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Insmed, Inc. | -260.0% |
| Merck & Co., Inc. | 18.06% |
| Beta Bionics, Inc. | -41.92% |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -60.42% |
| Return on Invested Capital | -91.28% |
| Gross Profit Margin (Quarterly) | 64.82% |
| Operating Margin (Quarterly) | -89.63% |
| Return on Net Operating Assets | -285.8% |